Literature DB >> 10320034

Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells.

M Miloso1, A A Bertelli, G Nicolini, G Tredici.   

Abstract

Phosphorylation of the mitogen-activated protein (MAP) kinases, extracellular signal-regulated kinase 1 (ERK1) and extracellular signal-regulated kinase 2 (ERK2), induced by resveratrol, a natural antioxidant present in grapes and wine, has been studied in vitro on undifferentiated and differentiated (induction by retinoic acid) SH-SY5Y human neuroblastoma cells. In undifferentiated cells resveratrol 1 microM induced phosphorylation of ERK1 and ERK2, which was already evident at 2 min, peaked at 10 min and persisted at 30 min. A wide range (from 1 pM to 10 microM) of resveratrol concentrations were able to induce phosphorylation of ERK1 and ERK2, while higher concentrations (50-100 microM) inhibited MAP kinases phosphorylation. In retinoic acid (RA) differentiated cells resveratrol (1 microM) induced an evident increase in ERK1 and ERK2 phosphorylation. This study demonstrates that resveratrol, even at very low concentrations, may have a biological effect on neuron-like cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320034     DOI: 10.1016/s0304-3940(99)00194-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.

Authors:  Nicolas G Azios; Lakshmi Krishnamoorthy; Micheleen Harris; Luis A Cubano; Michael Cammer; Surangani F Dharmawardhane
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

2.  Resveratrol inhibits Erk1/2-mediated adhesion of cancer cells via activating PP2A-PTEN signaling network.

Authors:  Xin Chen; Xiaoyu Hu; Yue Li; Cuilan Zhu; Xiaoqing Dong; Ruijie Zhang; Jing Ma; Shile Huang; Long Chen
Journal:  J Cell Physiol       Date:  2018-08-01       Impact factor: 6.384

3.  Immortalization of epithelial progenitor cells mediated by resveratrol.

Authors:  V P Pearce; J Sherrell; Z Lou; L Kopelovich; W E Wright; J W Shay
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

4.  Zhangfei induces the expression of the nerve growth factor receptor, trkA, in medulloblastoma cells and causes their differentiation or apoptosis.

Authors:  Ximena Valderrama; Noreen Rapin; Valerie M K Verge; Vikram Misra
Journal:  J Neurooncol       Date:  2008-08-22       Impact factor: 4.130

5.  Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C.

Authors:  Ying-Shan Han; Wen-Hua Zheng; Stéphane Bastianetto; Jean-Guy Chabot; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2004-03       Impact factor: 8.739

Review 6.  Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Authors:  Poyil Pratheeshkumar; Chakkenchath Sreekala; Zhuo Zhang; Amit Budhraja; Songze Ding; Young-Ok Son; Xin Wang; Andrew Hitron; Kim Hyun-Jung; Lei Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

7.  Embryoid body test with morphological and molecular endpoints implicates potential developmental toxicity of trans-resveratrol.

Authors:  Iris Q Kim; Yusuke Marikawa
Journal:  Toxicol Appl Pharmacol       Date:  2018-07-07       Impact factor: 4.219

8.  Resveratrol: French paradox revisited.

Authors:  Betul Catalgol; Saime Batirel; Yavuz Taga; Nesrin Kartal Ozer
Journal:  Front Pharmacol       Date:  2012-07-17       Impact factor: 5.810

9.  Resveratrol inhibits Cdk5 activity through regulation of p35 expression.

Authors:  Elias Utreras; Anita Terse; Jason Keller; Michael J Iadarola; Ashok B Kulkarni
Journal:  Mol Pain       Date:  2011-07-07       Impact factor: 3.395

10.  Resveratrol represses YKL-40 expression in human glioma U87 cells.

Authors:  Wei Zhang; Koji Murao; Xiang Zhang; Kensuke Matsumoto; Suwarni Diah; Masaki Okada; Keisuke Miyake; Nobuyuki Kawai; Zhou Fei; Takashi Tamiya
Journal:  BMC Cancer       Date:  2010-10-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.